# Adjuvant Proton Therapy or IMRT for the Treatment of Bladder Cancer

> **NCT01520038** · PHASE1,PHASE2 · COMPLETED · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 2 (actual)

## Conditions studied

- Urothelial Carcinoma of the Bladder

## Interventions

- **RADIATION:** Proton therapy
- **RADIATION:** IMRT

## Key facts

- **NCT ID:** NCT01520038
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2019-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01520038

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01520038, "Adjuvant Proton Therapy or IMRT for the Treatment of Bladder Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01520038. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*